248 related articles for article (PubMed ID: 12586510)
1. Hydrophilic and hydrophobic cyclodextrins in a new sustained release oral formulation of nicardipine: in vitro evaluation and bioavailability studies in rabbits.
Fernandes CM; Ramos P; Falcão AC; Veiga FJ
J Control Release; 2003 Feb; 88(1):127-34. PubMed ID: 12586510
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic delivery and metabolizing rate of nicardipine incorporated in hydrophilic and hydrophobic cyclodextrins using two-compartment mathematical model.
Shityakov S; Förster C
ScientificWorldJournal; 2013; 2013():131358. PubMed ID: 24391458
[TBL] [Abstract][Full Text] [Related]
3. Effect of the hydrophobic nature of triacetyl-beta-cyclodextrin on the complexation with nicardipine hydrochloride: physicochemical and dissolution properties of the kneaded and spray-dried complexes.
Fernandes CM; Veiga FJ
Chem Pharm Bull (Tokyo); 2002 Dec; 50(12):1597-602. PubMed ID: 12499598
[TBL] [Abstract][Full Text] [Related]
4. The physicochemical characteristics and bioavailability of indomethacin from beta-cyclodextrin, hydroxyethyl-beta-cyclodextrin, and hydroxypropyl-beta-cyclodextrin complexes.
Jambhekar S; Casella R; Maher T
Int J Pharm; 2004 Feb; 270(1-2):149-66. PubMed ID: 14726131
[TBL] [Abstract][Full Text] [Related]
5. Multimodal molecular encapsulation of nicardipine hydrochloride by beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin and triacetyl-beta-cyclodextrin in solution. Structural studies by 1H NMR and ROESY experiments.
Fernandes CM; Carvalho RA; Pereira da Costa S; Veiga FJ
Eur J Pharm Sci; 2003 Apr; 18(5):285-96. PubMed ID: 12694880
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds.
Fernandes CM; Teresa Vieira M; Veiga FJ
Eur J Pharm Sci; 2002 Feb; 15(1):79-88. PubMed ID: 11803134
[TBL] [Abstract][Full Text] [Related]
7. Design and in-vitro evaluation of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcellulose.
Wang Z; Horikawa T; Hirayama F; Uekama K
J Pharm Pharmacol; 1993 Nov; 45(11):942-6. PubMed ID: 7908033
[TBL] [Abstract][Full Text] [Related]
8. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714
[TBL] [Abstract][Full Text] [Related]
9. Improvement of dissolution and bioavailability of nitrendipine by inclusion in hydroxypropyl-beta-cyclodextrin.
Choi HG; Kim DD; Jun HW; Yoo BK; Yong CS
Drug Dev Ind Pharm; 2003 Nov; 29(10):1085-94. PubMed ID: 14677769
[TBL] [Abstract][Full Text] [Related]
10. Modulated dissolution rate from the inclusion complex of antichagasic benznidazole and cyclodextrin using hydrophilic polymer.
Sá-Barreto LC; Gustmann PC; Garcia FS; Maximiano FP; Novack KM; Cunha-Filho MS
Pharm Dev Technol; 2013; 18(5):1035-41. PubMed ID: 22200091
[TBL] [Abstract][Full Text] [Related]
11. Design and in vitro evaluation of slow-release dosage form of piretanide: utility of beta-cyclodextrin:cellulose derivative combination as a modified-release drug carrier.
Uekama K; Matsubara K; Abe K; Horiuchi Y; Hirayama F; Suzuki N
J Pharm Sci; 1990 Mar; 79(3):244-8. PubMed ID: 2338635
[TBL] [Abstract][Full Text] [Related]
12. Preparation and in-vitro release rate of fentanyl-cyclodextrin complexes for prolonged action in epidural analgesia.
Holvoet C; Plaizier-Vercammen J; Vander Heyden Y; Gabriëls M; Camu F
Int J Pharm; 2003 Oct; 265(1-2):13-26. PubMed ID: 14522114
[TBL] [Abstract][Full Text] [Related]
13. In-vivo and in-vitro evaluations of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcelluloses in dogs.
Wang Z; Hirayama F; Uekama K
J Pharm Pharmacol; 1994 Jun; 46(6):505-7. PubMed ID: 7932048
[TBL] [Abstract][Full Text] [Related]
14. Potential Use of Cyclodextrin Complexes for Enhanced Stability, Anti-inflammatory Efficacy, and Ocular Bioavailability of Loteprednol Etabonate.
Soliman OAE; Mohamed EAM; El-Dahan MS; Khatera NAA
AAPS PharmSciTech; 2017 May; 18(4):1228-1241. PubMed ID: 27469220
[TBL] [Abstract][Full Text] [Related]
15. [Development and pharmaceutical evaluation of hydrophobic cyclodextrin derivatives as modified-release drug carriers].
Hirayama F
Yakugaku Zasshi; 1993 Jun; 113(6):425-37. PubMed ID: 8355145
[TBL] [Abstract][Full Text] [Related]
16. Formulation and evaluation of sustained release floating capsules of nicardipine hydrochloride.
Moursy NM; Afifi NN; Ghorab DM; El-Saharty Y
Pharmazie; 2003 Jan; 58(1):38-43. PubMed ID: 12622251
[TBL] [Abstract][Full Text] [Related]
17. Effect of hydroxypropyl-beta-cyclodextrin on the antimicrobial action of preservatives.
Lehner SJ; Müller BW; Seydel JK
J Pharm Pharmacol; 1994 Mar; 46(3):186-91. PubMed ID: 8027925
[TBL] [Abstract][Full Text] [Related]
18. Cyclodextrin multicomponent complexation and controlled release delivery strategies to optimize the oral bioavailability of vinpocetine.
Ribeiro LS; Falcão AC; Patrício JA; Ferreira DC; Veiga FJ
J Pharm Sci; 2007 Aug; 96(8):2018-28. PubMed ID: 17530626
[TBL] [Abstract][Full Text] [Related]
19. Sustained release of flufenamic acid from a drug-triacetyl-beta-cyclodextrin complex.
Nakanishi K; Masukawa T; Nadai T; Yoshii K; Okada S; Miyajima K
Biol Pharm Bull; 1997 Jan; 20(1):66-70. PubMed ID: 9013809
[TBL] [Abstract][Full Text] [Related]
20. Slow-release characteristics of diltiazem from ethylated beta-cyclodextrin complexes.
Horiuchi Y; Hirayama F; Uekama K
J Pharm Sci; 1990 Feb; 79(2):128-32. PubMed ID: 2324960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
